About Idera

Idera Pharmaceuticals is a clinical stage biotechnology company developing a novel approach to the potential treatment of autoimmune and inflammatory diseases.

Idera’s drug candidates are designed to modulate immune responses through Toll-like Receptors (TLRs).

Idera also is collaborating with Merck & Co. for TLR-targeted compounds for use as vaccine adjuvants.

Therapeutic Areas

> AUTOIMMUNE DISEASES
> VACCINE ADJUVANTS

Partnering Opportunities

> CANCER
> RESPIRATORY DISEASES
> INFECTIOUS DISEASES
> TLR3 AGONISTS
> GENE-SILENCING OLIGONUCLEOTIDES